Home
>
National Drug Code (NDC)
>
ALDURAZYME
ALDURAZYME - 58468-0070-1 - (laronidase)
Drug Information of ALDURAZYME
| Product NDC: | 58468-0070 |
| Proprietary Name: | ALDURAZYME |
| Non Proprietary Name: | laronidase |
| Active Ingredient(s): | 2.9 mg/5mL & nbsp; laronidase |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ALDURAZYME
| Product NDC: | 58468-0070 |
| Labeler Name: | Genzyme Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125058 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20030430 |
Package Information of ALDURAZYME
| Package NDC: | 58468-0070-1 |
| Package Description: | 5 mL in 1 VIAL, GLASS (58468-0070-1) |
NDC Information of ALDURAZYME
| NDC Code | 58468-0070-1 |
| Proprietary Name | ALDURAZYME |
| Package Description | 5 mL in 1 VIAL, GLASS (58468-0070-1) |
| Product NDC | 58468-0070 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | laronidase |
| Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20030430 |
| Marketing Category Name | BLA |
| Labeler Name | Genzyme Corporation |
| Substance Name | LARONIDASE |
| Strength Number | 2.9 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | alpha-Glucosidases [Chemical/Ingredient],Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] |
